Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Mar;71(3):1766-75.
doi: 10.1128/JVI.71.3.1766-1775.1997.

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus

Affiliations

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus

A L Kirchmaier et al. J Virol. 1997 Mar.

Abstract

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1) is required in trans to support replication of the EBV genome once per cell cycle via the latent origin of replication, oriP. EBNA-1 can also activate transcription on binding to the family of repeats of oriP to enhance some heterologous as well as native EBV promoters. We have made and screened derivatives of EBNA-1 for the ability to act as inhibitors of wild-type EBNA-1. These derivatives lack the linking or the retention functions of EBNA-1 and were analyzed for the residual ability to activate transcription and replication. We have identified derivatives of EBNA-1 that can inhibit up to 98% of wild-type EBNA-1's activities. We have also identified one derivative of EBNA-1 with only two of EBNA-1's three linking domains which can support transcription and replication inefficiently.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Cell Biol. 1985 Oct;5(10):2533-42 - PubMed
    1. Cell. 1985 Oct;42(3):859-68 - PubMed
    1. Mol Cell Biol. 1986 Nov;6(11):3838-46 - PubMed
    1. Anal Biochem. 1987 Jul;164(1):44-52 - PubMed
    1. Nucleic Acids Res. 1988 Apr 25;16(8):3415-35 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources